{"id":19730,"date":"2017-02-17T12:01:41","date_gmt":"2017-02-17T11:01:41","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=19730"},"modified":"2019-04-16T15:51:48","modified_gmt":"2019-04-16T13:51:48","slug":"immunic-investment-round","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/19730\/immunic-investment-round\/","title":{"rendered":"Immunic expands investment round by four million euros"},"content":{"rendered":"<div class=\"entry-content\"><p><strong>Immunic AG, a young biotech company based in <a href=\"\/en\/19098\/asked-at-the-izb\/\" target=\"_blank\" rel=\"noopener\">IZB in Martinsried <\/a>near Munich, was able to <a href=\"\/en\/14741\/immunic-receives-175-million-euros-in-financing\/\" target=\"_blank\" rel=\"noopener\">recently completed first investment round\u00a0<\/a> to a total of 21.7 million euros.<\/strong><\/p>\n<p>IBG Risikokapitalfonds II GmbH &amp; Co. KG has joined the international investor consortium as a new investor, led by the Dutch lead investor LSP and the co-lead investor LifeCarePartners.<\/p>\n<p>The <a href=\"http:\/\/www.immunic.de\/\" target=\"_blank\" rel=\"noopener\">Immunic AG<\/a> was founded in April 2016 with the goal of bringing targeted pharmaceutical development projects to clinical proof of concept. The company develops products in the field of chronic inflammatory and autoimmune diseases, such as ulcerative colitis, Crohn&#039;s disease, and psoriasis.<\/p>\n<h3>Investment round expanded: \u201cThis step is particularly important\u201d<\/h3>\n<p><strong>Dr. Daniel Vitt<\/strong>, Immunics CEO and Spokesperson, says:<\/p>\n<blockquote><p>&quot;We are very pleased that IBG has expanded our investor base, allowing us to raise an additional four million euros in equity financing. This step is particularly important for the rapid further development of our two lead products (...) for the treatment of autoimmune diseases with high medical need.&quot;<\/p><\/blockquote>\n<h3>\u201cOutstanding therapeutic products\u201d<\/h3>\n<blockquote><p>\u201cWe are convinced that Immunic\u2019s outstanding therapeutic products, managed by an experienced development team, will sustainably improve the treatment options for chronic inflammatory diseases,\u201d<\/p><\/blockquote>\n<p>says <strong>Dr. Angelika Vlachou<\/strong>, Investment Manager at bmp.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Immunic AG, a young biotech company headquartered at the IZB in Martinsried near Munich, has increased its recently completed first investment round to a total of \u20ac21.7 million. IBG Risikokapitalfonds II GmbH &amp; Co. KG has joined the international investor consortium, which is led by Dutch lead investor LSP and the\u2026<\/p>","protected":false},"author":3,"featured_media":19749,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,2294],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Immunic erweitert Investitionsrunde um vier Millionen Euro - Munich Startup<\/title>\n<meta name=\"description\" content=\"Die Immunic AG konnte seine erst k\u00fcrzlich abgeschlossene erste Investitionsrunde auf nun insgesamt 21,7 Millionen Euro erh\u00f6hen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/19730\/immunic-investment-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunic erweitert Investitionsrunde um vier Millionen Euro - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Die Immunic AG konnte seine erst k\u00fcrzlich abgeschlossene erste Investitionsrunde auf nun insgesamt 21,7 Millionen Euro erh\u00f6hen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/19730\/immunic-investment-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-17T11:01:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-04-16T13:51:48+00:00\" \/>\n<meta name=\"author\" content=\"Florian Deglmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FlorianDeglmann\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florian Deglmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/\",\"url\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/\",\"name\":\"Immunic erweitert Investitionsrunde um vier Millionen Euro - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg\",\"datePublished\":\"2017-02-17T11:01:41+00:00\",\"dateModified\":\"2019-04-16T13:51:48+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\"},\"description\":\"Die Immunic AG konnte seine erst k\u00fcrzlich abgeschlossene erste Investitionsrunde auf nun insgesamt 21,7 Millionen Euro erh\u00f6hen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg\",\"width\":1264,\"height\":640,\"caption\":\"Immunic Forschungsf\u00f6rderung\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunic erweitert Investitionsrunde um vier Millionen Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251\",\"name\":\"Florian Deglmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g\",\"caption\":\"Florian Deglmann\"},\"description\":\"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.\",\"sameAs\":[\"http:\/\/cms.munich-startup.net\",\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\",\"https:\/\/x.com\/FlorianDeglmann\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1264\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunic expands investment round by four million euros - Munich Startup","description":"Immunic AG was able to increase its recently completed first investment round to a total of 21.7 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/19730\/immunic-investment-round\/","og_locale":"en_US","og_type":"article","og_title":"Immunic erweitert Investitionsrunde um vier Millionen Euro - Munich Startup","og_description":"Die Immunic AG konnte seine erst k\u00fcrzlich abgeschlossene erste Investitionsrunde auf nun insgesamt 21,7 Millionen Euro erh\u00f6hen.","og_url":"https:\/\/cms.munich-startup.net\/en\/19730\/immunic-investment-round\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_author":"https:\/\/www.facebook.com\/profile.php?id=100009572160192","article_published_time":"2017-02-17T11:01:41+00:00","article_modified_time":"2019-04-16T13:51:48+00:00","author":"Florian Deglmann","twitter_card":"summary_large_image","twitter_creator":"@FlorianDeglmann","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Florian Deglmann","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/","url":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/","name":"Immunic expands investment round by four million euros - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg","datePublished":"2017-02-17T11:01:41+00:00","dateModified":"2019-04-16T13:51:48+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251"},"description":"Immunic AG was able to increase its recently completed first investment round to a total of 21.7 million euros.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg","width":1264,"height":640,"caption":"Immunic Forschungsf\u00f6rderung"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/19730\/immunic-investitionsrunde\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Immunic erweitert Investitionsrunde um vier Millionen Euro"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/2371b77bb47cd783e9e1f88e88d9f251","name":"Florian Deglmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e3087740aeaedbec23f0c7300f1beeb?s=96&d=blank&r=g","caption":"Florian Deglmann"},"description":"The exiled Nuremberg resident researched the Munich startup scene as an editor until April 2019.","sameAs":["http:\/\/cms.munich-startup.net","https:\/\/www.facebook.com\/profile.php?id=100009572160192","https:\/\/x.com\/FlorianDeglmann"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/deglmann\/"}]},"og_image":[{"width":1264,"height":640,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2017\/02\/Immunic-e1568190771576.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1555422571:3","_edit_last":"3","_yoast_wpseo_focuskw":"Investitionsrunde","_yoast_wpseo_metadesc":"Die Immunic AG konnte seine erst k\u00fcrzlich abgeschlossene erste Investitionsrunde auf nun insgesamt 21,7 Millionen Euro erh\u00f6hen.","_yoast_wpseo_linkdex":"74","_thumbnail_id":"19749","wbounce_status":"default","_yoast_wpseo_primary_category":"","_yoast_wpseo_focuskw_text_input":"Investitionsrunde","_yoast_wpseo_content_score":"30","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"immunic-erweitert-investitionsrunde-um-vier-millionen-euro","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/19730"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=19730"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/19730\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/19749"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=19730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=19730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=19730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}